Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene

Autor: Wan, Emily S, Castaldi, Peter J, Cho, Michael H, Hokanson, John E, Regan, Elizabeth A, Make, Barry J, Beaty, Terri H, Han, MeiLan K, Curtis, Jeffrey L, Curran-Everett, Douglas, Lynch, David A, DeMeo, Dawn L, Crapo, James D, Silverman, Edwin K, COPDGene Investigators
Rok vydání: 2014
Předmět:
Male
Multivariate analysis
Cross-sectional study
Respiratory System
Genome-wide association study
Cardiorespiratory Medicine and Haematology
Cohort Studies
Pulmonary Disease
Chronic Obstructive

0302 clinical medicine
Epidemiology
80 and over
Restriction
Cluster Analysis
2.1 Biological and endogenous factors
030212 general & internal medicine
Aetiology
Lung
Aged
80 and over

COPD
medicine.diagnostic_test
Smoking
Middle Aged
3. Good health
Respiratory
Female
Cohort study
Spirometry
Pulmonary and Respiratory Medicine
medicine.medical_specialty
Chronic Obstructive
Chronic Obstructive Pulmonary Disease
Clinical Sciences
Pulmonary Disease
03 medical and health sciences
FEV1/FVC ratio
Clinical Research
Internal medicine
Tobacco
medicine
Genetics
Humans
Lung diseases
Aged
COPDGene Investigators
Tobacco Smoke and Health
business.industry
Research
Human Genome
medicine.disease
eye diseases
Good Health and Well Being
Cross-Sectional Studies
030228 respiratory system
Physical therapy
business
Genome-Wide Association Study
Zdroj: Respiratory research, vol 15, iss 1
Wan, E S, Castaldi, P J, Cho, M H, Hokanson, J E, Regan, E A, Make, B J, Beaty, T H, Han, M K, Curtis, J L, Curran-Everett, D, Lynch, D A, DeMeo, D L, Crapo, J D, Silverman, E K, COPDGene Investigators & Mattheisen, M 2014, ' Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene ' Respiratory Research Review, vol. 15, pp. 89 . https://doi.org/10.1186/s12931-014-0089-y
Respiratory Research
Popis: Background Preserved Ratio Impaired Spirometry (PRISm), defined as a reduced FEV1 in the setting of a preserved FEV1/FVC ratio, is highly prevalent and is associated with increased respiratory symptoms, systemic inflammation, and mortality. Studies investigating quantitative chest tomographic features, genetic associations, and subtypes in PRISm subjects have not been reported. Methods Data from current and former smokers enrolled in COPDGene (n = 10,192), an observational, cross-sectional study which recruited subjects aged 45–80 with ≥10 pack years of smoking, were analyzed. To identify epidemiological and radiographic predictors of PRISm, we performed univariate and multivariate analyses comparing PRISm subjects both to control subjects with normal spirometry and to subjects with COPD. To investigate common genetic predictors of PRISm, we performed a genome-wide association study (GWAS). To explore potential subgroups within PRISm, we performed unsupervised k-means clustering. Results The prevalence of PRISm in COPDGene is 12.3%. Increased dyspnea, reduced 6-minute walk distance, increased percent emphysema and decreased total lung capacity, as well as increased segmental bronchial wall area percentage were significant predictors (p-value
Databáze: OpenAIRE